机构：[1]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, and Key Laboratory of Neurodegenerative Diseases (Ministry of Education), Beijing 100053, China内科系统科技平台老年医学科神经变性病教育部重点实验室首都医科大学宣武医院[2]Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing 100053, China神经科系统神经外科首都医科大学宣武医院[3]Clinical Research Center for Epilepsy Capital Medical University, Bejing 100053, China[4]Beijing Municipal Geriatric Medical Research Center, Beijing 100053, China[5]Center of Neural Ijury and Repair, Beijing Institute for Brain Disorders, Beijing 100069, China[6]Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing 100069, China
第一作者机构：[1]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, and Key Laboratory of Neurodegenerative Diseases (Ministry of Education), Beijing 100053, China[5]Center of Neural Ijury and Repair, Beijing Institute for Brain Disorders, Beijing 100069, China[6]Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing 100069, China
通讯作者：
通讯机构：[1]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, and Key Laboratory of Neurodegenerative Diseases (Ministry of Education), Beijing 100053, China[2]Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing 100053, China[3]Clinical Research Center for Epilepsy Capital Medical University, Bejing 100053, China[4]Beijing Municipal Geriatric Medical Research Center, Beijing 100053, China[5]Center of Neural Ijury and Repair, Beijing Institute for Brain Disorders, Beijing 100069, China[6]Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing 100069, China
推荐引用方式(GB/T 7714)：
Chen Zhiguo,Zhao Guoguang.First-in-human transplantation of autologous induced neural stem cell-derived dopaminergic precursors to treat Parkinson's disease[J].SCIENCE BULLETIN.2023,68(22):2700-2703.doi:10.1016/j.scib.2023.10.020.
APA：
Chen Zhiguo&Zhao Guoguang.(2023).First-in-human transplantation of autologous induced neural stem cell-derived dopaminergic precursors to treat Parkinson's disease.SCIENCE BULLETIN,68,(22)
MLA：
Chen Zhiguo,et al."First-in-human transplantation of autologous induced neural stem cell-derived dopaminergic precursors to treat Parkinson's disease".SCIENCE BULLETIN 68..22(2023):2700-2703
综合性期刊